Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
NYSE
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's latest marketcap:
As of 06/07/2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market capitalization has reached $5.77 B. According to our data, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is the 2906th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.77 B |
| Revenue (ttm) | 10.36 B |
| Net Income (ttm) | 375.12 M |
| Shares Out | 0 |
| EPS (ttm) | 0.23 |
| Forward PE | 14.25 |
| Ex-Dividend Date | 10/25/2024 |
| Earnings Date | 08/29/2025 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | ¥41.51 B | -5.08% |
| 12/31/2024 | ¥43.72 B | -1.87% |
| 12/29/2023 | ¥44.55 B | -3.89% |
| 12/30/2022 | ¥46.36 B | -11.03% |
| 12/31/2021 | ¥52.1 B | 16.71% |
| 12/31/2020 | ¥44.64 B |
Company Profile
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, along with its subsidiaries, is a leading pharmaceutical company specializing in the research, development, manufacturing, and sale of:
- Chinese patent medicines
- Western medicines
- Chemical raw materials
- Natural and biological medicines
- Intermediates of chemical raw materials
The company operates primarily in China and internationally, serving diverse healthcare needs.
Business Segments
The company is structured into four key segments:
- Great Southern TCM – Focuses on traditional Chinese medicine
- Great Commerce – Handles wholesale and retail distribution
- Great Health – Engages in health and wellness products
- Other segments – Includes additional business operations
Product and Service Offerings
Beyond pharmaceuticals, Guangzhou Baiyunshan provides:
- Wholesale and retail of medical instruments, healthcare products, and equipment
- Import and export of pharmaceutical goods
- Production of beverages, food, and health supplements
- Pre-packaged food and dairy products
- Herbal teas, tablets, capsules, and tortoise herb jelly
The company also invests in:
- Medical services and health management
- Elderly care and wellness programs
- Commercial leasing and advertising services
Operations and History
The company operates through:
- Retail chain pharmacy stores
- Dedicated retail outlets
Formerly known as Guangzhou Pharmaceutical Company Limited, the company rebranded to its current name in August 2013. Founded in 1997, it is headquartered in Guangzhou, China.
Frequently Asked Questions
-
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (SHA-600332) current market cap?As of 06/07/2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (including the parent company, if applicable) has an estimated market capitalization of $5.77 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA-600332) rank globally by market cap?Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited global market capitalization ranking is approximately 2906 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.